tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AU:NSB Stock Latest News

NeuroScientific Advances StemSmart™ Program as Crohn’s Trial Prep Gathers Pace
Company AnnouncementsNeuroScientific Advances StemSmart™ Program as Crohn’s Trial Prep Gathers Pace
6d ago
NSB
NeuroScientific’s StemSmart Therapy Delivers Strong Results in Fistulising Crohn’s Patients
PremiumCompany Announcements
NeuroScientific’s StemSmart Therapy Delivers Strong Results in Fistulising Crohn’s Patients
23d ago
NSB
NeuroScientific Biopharmaceuticals Advances Therapeutics for Crohn’s Disease and Neuroprotection
PremiumCompany Announcements
NeuroScientific Biopharmaceuticals Advances Therapeutics for Crohn’s Disease and Neuroprotection
3M ago
NSB
NeuroScientific Biopharmaceuticals to Host Investor Webinar on Strategic Advances
PremiumCompany Announcements
NeuroScientific Biopharmaceuticals to Host Investor Webinar on Strategic Advances
3M ago
NSB
NeuroScientific Advances StemSmart™ Therapy for Crohn’s Disease
PremiumCompany Announcements
NeuroScientific Advances StemSmart™ Therapy for Crohn’s Disease
3M ago
NSB
NeuroScientific Biopharmaceuticals Establishes Advisory Board to Drive Innovation
PremiumCompany AnnouncementsNeuroScientific Biopharmaceuticals Establishes Advisory Board to Drive Innovation
3M ago
NSB
NeuroScientific Biopharmaceuticals Advances StemSmart™ for Crohn’s Disease with Strategic Appointments and Partnerships
Premium
Company Announcements
NeuroScientific Biopharmaceuticals Advances StemSmart™ for Crohn’s Disease with Strategic Appointments and Partnerships
3M ago
NSB
Neuroscientific Biopharmaceuticals Expands Manufacturing and Proves Clinical Efficacy
Premium
Company Announcements
Neuroscientific Biopharmaceuticals Expands Manufacturing and Proves Clinical Efficacy
4M ago
NSB
NeuroScientific’s StemSmart™ Gains TGA Approval for Crohn’s Disease Treatment
PremiumCompany Announcements
NeuroScientific’s StemSmart™ Gains TGA Approval for Crohn’s Disease Treatment
4M ago
NSB
NeuroScientific Biopharmaceuticals Announces Annual General Meeting Details
PremiumCompany Announcements
NeuroScientific Biopharmaceuticals Announces Annual General Meeting Details
4M ago
NSB
NeuroScientific Biopharmaceuticals Announces Annual General Meeting
PremiumCompany Announcements
NeuroScientific Biopharmaceuticals Announces Annual General Meeting
4M ago
NSB
Neuroscientific Biopharmaceuticals Announces Change in Substantial Holding
PremiumCompany Announcements
Neuroscientific Biopharmaceuticals Announces Change in Substantial Holding
5M ago
NSB
NeuroScientific Biopharmaceuticals Announces AGM and Director Nomination Deadline
PremiumCompany AnnouncementsNeuroScientific Biopharmaceuticals Announces AGM and Director Nomination Deadline
5M ago
NSB
Neuroscientific Biopharmaceuticals Issues New Equity Securities
Premium
Company Announcements
Neuroscientific Biopharmaceuticals Issues New Equity Securities
5M ago
NSB
Neuroscientific Biopharmaceuticals Ltd. Releases Corporate Governance Statement
Premium
Company Announcements
Neuroscientific Biopharmaceuticals Ltd. Releases Corporate Governance Statement
5M ago
NSB
NeuroScientific Biopharmaceuticals Faces Financial Challenges Amidst Industry Struggles
PremiumCompany Announcements
NeuroScientific Biopharmaceuticals Faces Financial Challenges Amidst Industry Struggles
5M ago
NSB
NeuroScientific Biopharmaceuticals Reports Promising Results for StemSmart MSC in Renal Transplantation
PremiumCompany Announcements
NeuroScientific Biopharmaceuticals Reports Promising Results for StemSmart MSC in Renal Transplantation
5M ago
NSB
NeuroScientific Biopharmaceuticals Highlights Stem Cell Innovations at TechKnow Invest Roadshow
PremiumCompany Announcements
NeuroScientific Biopharmaceuticals Highlights Stem Cell Innovations at TechKnow Invest Roadshow
6M ago
NSB
NeuroScientific Biopharmaceuticals Partners with Q-Gen to Advance StemSmart™ Technology
PremiumCompany Announcements
NeuroScientific Biopharmaceuticals Partners with Q-Gen to Advance StemSmart™ Technology
6M ago
NSB
NeuroScientific Biopharmaceuticals Appoints New CEO to Drive StemSmart Technology Development
PremiumCompany AnnouncementsNeuroScientific Biopharmaceuticals Appoints New CEO to Drive StemSmart Technology Development
6M ago
NSB
NeuroScientific Biopharmaceuticals Appoints Dr. Catherine Cole as Chief Medical Officer
Premium
Company Announcements
NeuroScientific Biopharmaceuticals Appoints Dr. Catherine Cole as Chief Medical Officer
7M ago
NSB
NeuroScientific Biopharmaceuticals Expands Stem Cell Therapy Portfolio with Key Acquisition
Premium
Company Announcements
NeuroScientific Biopharmaceuticals Expands Stem Cell Therapy Portfolio with Key Acquisition
7M ago
NSB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >